XML 160 R100.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Related party disclosures (Details) € in Thousands |  |  |  |  | 1 Months Ended | 3 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | ---
Mar. 22, 2024 shares | Dec. 12, 2022 shares | Oct. 18, 2021 shares | Mar. 10, 2021 shares | Aug. 31, 2023 EUR (€) | May 31, 2022 EUR (€) | Mar. 31, 2023 EUR (€) | Dec. 31, 2023 EUR (€) shares | Dec. 31, 2022 EUR (€) shares | Dec. 31, 2021 EUR (€) shares | Dec. 31, 2021 $ / shares shares | Dec. 31, 2019 loan | Sep. 30, 2021 EUR (€)
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Consulting fees |  |  |  |  |  |  |  | € 212 | € 518 |  |  |  |
Amount paid |  |  |  |  |  |  |  |  |  | € 25,000 |  |  |
Common shares |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 16 |  |
Prior VSOP |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares received | shares | 786,746 | 777,260 | 765,223 | 759,677 |  |  |  | 0 | 777,260 |  |  |  |
Dietmar Hopp |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Number of convertible loans | loan |  |  |  |  |  |  |  |  |  |  |  | 2 |
Dietmar Hopp | Common shares |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares |  |  |  |  |  |  |  |  |  | 100,000,000 | 100,000,000 |  |
Dievini Hopp BioTech holding GmbH & Co. KG |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Reimbursement of travel cost |  |  |  |  |  |  |  | € 1 | € 58 |  |  |  |
Clarentis SRL |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Contractual obligation amount |  |  |  |  |  |  |  |  |  |  |  |  | € 100
Expense recognized from related party transaction |  |  |  |  |  |  |  | 107 |  |  |  |  |
BePharBel Manufacturing S.A |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Settlement amount |  |  |  |  |  | € 3,900 |  |  |  |  |  |  |
Amount paid |  |  |  |  |  |  |  |  |  | € 4,016 |  |  |
Franz-Werner Haas |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Expense recognized from related party transaction |  |  |  |  |  |  |  | 65 |  |  |  |  |
Payment compensated |  |  |  |  |  |  |  | 40 |  |  |  |  |
Alexander Zehnder |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Expenses to handle future service agreement |  |  |  |  |  |  | € 51 |  |  |  |  |  |
Barker BioMedical GmbH |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Expense recognized from related party transaction |  |  |  |  |  |  |  | 14 |  |  |  |  |
Craig Tooman |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Expense recognized from related party transaction |  |  |  |  |  |  |  | € 5 |  |  |  |  |
Rittershaus Rechtsanwaelte |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Notice period for termination at the option |  |  |  |  |  |  |  | 3 months |  |  |  |  |
Consulting fees |  |  |  |  |  |  |  |  |  | € 757 |  |  |
Service rendered issue |  |  |  |  |  |  |  | € 16 |  |  |  |  |
Mariola Fotin-Mleczek |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Consulting fees |  |  |  |  |  |  |  | 2 | 20 |  |  |  |
Income tax and social security liability receivable |  |  |  |  |  |  |  |  | 131 |  |  |  |
Florian von der Mlbe |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Income tax and social security liability receivable |  |  |  |  |  |  |  |  | 559 |  |  |  |
Dr. Ingmar Hrr |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Income tax and social security liability receivable |  |  |  |  |  |  |  |  | 573 |  |  |  |
Immatics Biotechnologies GmbH |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Equity interest held |  |  |  |  | 16.70% |  |  |  |  |  |  |  |
Purchases of related party |  |  |  |  | € 178 |  |  |  |  |  |  |  |
CureVac Printer GmbH |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Consulting fees |  |  |  |  |  |  |  | 146 |  |  |  |  |
Grid Europe |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Expense recognized from related party transaction |  |  |  |  |  |  |  | 23 |  |  |  |  |
Baron Jean Stephenne |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Equity interest held |  |  |  |  |  |  |  |  |  | 15.61% |  |  |
Vincent Stephenne |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Equity interest held |  |  |  |  |  |  |  |  |  | 1.43% |  |  |
Antony Blanc | Clarentis SRL |  |  |  |  |  |  |  |  |  |  |  |  |
Related party disclosures |  |  |  |  |  |  |  |  |  |  |  |  |
Consulting fees |  |  |  |  |  |  |  | € 85 | € 69 | € 0 |  |  |

X
- Definition Amount of expense recognized during the period from related party transaction. + References No definition available. + Details
Name: | cvac_ExpenseRecognizedFromRelatedPartyTransaction
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of expenses to handle future service agreement. + References No definition available. + Details
Name: | cvac_ExpensesToHandleFutureServiceAgreement
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments. + References No definition available. + Details
Name: | cvac_IfrsContractualObligation
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of shares received from the participants. + References No definition available. + Details
Name: | cvac_IfrsNumberOfSharesOutstandingThroughTransferFromShareholdersToEntity
Namespace Prefix: | cvac_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of income tax and social security liability receivable. + References No definition available. + Details
Name: | cvac_IncomeTaxAndSocialSecurityLiabilityReceivable
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount reimbursed to the company in the form of kind from related party transaction. + References No definition available. + Details
Name: | cvac_ReimbursementOfExpenseInFormOfKindFromRelatedPartyTransaction
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of reimbursement of travel cost. + References No definition available. + Details
Name: | cvac_ReimbursementOfTravelCost
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of consulting fees incurred as a part of related party transaction. + References No definition available. + Details
Name: | cvac_RelatedPartyTransactionConsultingFees
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Period of notice for termination of the agreement at the option of the party. + References No definition available. + Details
Name: | cvac_RelatedPartyTransactionNoticePeriodForTerminationOfAgreement
Namespace Prefix: | cvac_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of loans received from a related party. + References No definition available. + Details
Name: | cvac_RelatedPartyTransactionNumberOfLoansReceived
Namespace Prefix: | cvac_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of service rendered. + References No definition available. + Details
Name: | cvac_ServiceRenderedIssue
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of related-party commitments made by the entity to do something if a particular event occurs or does not occur in the future, including executory contracts (recognised and unrecognised). [Refer: Related parties [member]] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 24 -IssueDate 2023-01-01 -Paragraph 21 -Subparagraph i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_21_i&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of shares issued by the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 106 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_NumberOfSharesIssued
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2023-01-01 -Paragraph 17 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_iii&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2023-01-01 -Paragraph 16 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_iii&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2023-01-01 -Paragraph 21 -Subparagraph a -Clause iv -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_21_a_iv&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ProportionOfOwnershipInterestInAssociate
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of goods purchased by the entity in related party transactions. [Refer: Related parties [member]] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 24 -IssueDate 2023-01-01 -Paragraph 21 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_21_a&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_PurchasesOfGoodsRelatedPartyTransactions
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 7 -IssueDate 2023-01-01 -Paragraph 17 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_d&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The weighted average share price. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_c&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_WeightedAverageSharePrice2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cvac_VirtualSharesProgramIMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cvac_DietmarHoppMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cvac_DieviniHoppBiotechHoldingGmbhCo.KgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cvac_ClarentisSrlMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cvac_BepharbelManufacturingS.aMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cvac_FranzWernerHaasMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cvac_AlexanderZehnderMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cvac_BarkerBiomedicalGmbhMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cvac_CraigToomanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cvac_RittershausRechtsanwaelteMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cvac_MariolaFotinMleczekMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cvac_FlorianVonDerMlbeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cvac_Dr.IngmarHrrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cvac_ImmaticsBiotechnologiesGmbhMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cvac_CurevacPrinterGmbhMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cvac_GridEuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=cvac_BaronJeanStephenneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=cvac_VincentStphenneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=cvac_AntonyBlancMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |